L29-15890-44746
2 vaccinations
4 coded responses
24 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 237 / VA
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Survey response — day 0, dose 1MedDRA: Pregnancy — Feeling: GoodFree text: 5 weeks pregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-08
- 2021-01-09
-
2021-01-10
Survey response — days 1–6 daily, dose 1MedDRA: Pregnancy, Symptom recurrence — Feeling: Fair · Headache, Fatigue or tiredness, NauseaFree text: 5 weeks pregnant; symptoms expectedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-14
- 2021-01-21
-
2021-01-25
Dose 2 — Pfizer-BioNTech
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-27
- 2021-01-28
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
-
2021-02-02
Call successfulParticipant prefers to complete VAERS report online
- 2021-02-08
-
2021-02-15
Survey response — day 21, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache x5 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-03-01
- 2021-03-08
- 2021-07-26
-
2022-01-25
Survey response — 12 months, dose 2MedDRA: Malaise, Office visit, SARS-CoV-2 test, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: COVID symptoms (tested negative x 2) for last 2 weeks. · Healthcare visit (other): COVID testing via employer occupational healthMedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): 5 weeks pregnant
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): 5 weeks pregnant; symptoms expected
Release 4 — day 21, dose 2
Symptoms: Headache x5 days
Release 11 — 12 months, dose 2
Symptoms: COVID symptoms (tested negative x 2) for last 2 weeks.
Healthcare visit (other): COVID testing via employer occupational health
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | SARS-CoV-2 test | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Exposure during pregnancy | ○ | ○ | ○ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Symptom recurrence | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release